Moreover, elevated 5‐LOX expression was associated with poor prognosis in LBC patients in these two cohorts (Figure 3K,L) and the public database (Figure S2H). This evidence concerns the gene ALOX5 and CDH1-related diffuse gastric and lobular breast cancer syndrome.